Curriculum Vitae

Scopus ID: 8922220000

Prof. Trevisson obtained her Medical Degree at the University of Padua and certification in Medical Genetics at the University of Siena. She earned her PhD in Rare Diseases (PhD School in Developmental Medicine, University of Padua). During her PhD program, supervised by Prof. Salviati, she set up models of neurometabolic conditions, mainly mitochondrial disorders and urea cycle defects.

Prof. Trevisson had also the opportunity to visit as fellow an excellent center of developmental biology in Spain (Centro Andaluz de Biologia del Desarrollo, Seville) in the Lab. of Prof. Navas, where she could work with C. elegans, that has been widely used in most research fields and she also established a knockdown model of a mitochondrial disorder.

Since March 2011, she works at the Dept. of Women’s and Children’s Health of the University of Padua as Assistant Professor and then, since 2020, as Associate Professor of Medical Genetics. Since 2014 she leads a group in the laboratory of Genetics at the Istituto di Ricerca Pediatrica (IRP), where she is following on with modeling human genetic diseases in C. elegans and D. rerio and she has started a novel research line on cancer genetics.

Being a medical geneticist, she also performs genetic consultations at the Clinical Genetics Unit of the Azienda Ospedale Università Padova, where she is in charge of the neurofibromatosis outpatient clinic. This clinical practice gave her the opportunity to deal with inherited tumor predisposing syndromes.

She teaches Molecular Genetics and Medical Genetics in different academic courses, medical residency programs and in the PhD program in neurosciences at the University of Padua.

She has co-authored 68 Medline publications and five book chapters, with a total impact factor of 278 (Journal of Citation reports 2016), h-index 22, total citations 1932 (according to Scopus).

E-mail: eva.trevisson@unipd.i

Latest pubblications: Click here

Related Laboratories

Model organisms and rare diseases

The main interest of our laboratory has been the development of models to study the genetic bases and the pathophysiology of inherited neurometabolic disorders.